JAK2 and colon adenocarcinoma: The JAK2/STAT3 signaling pathway upregulates the expression of Bcl2, cyclin D1, c-Myc, and other proteins linked to progression, drug resistance, and poor prognosis in COAD, LUAD, and BRCA [59].